SA

Sanjay Asyja

Director Director DIN 03178821
DIN 03178821 First appointment Sep 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Asyja

Data last updated:

Sanjay Asyja was a Director at Ananta Medicare Limited (2017–2024) and Director at Divyansh Exim Private Limited (from 2010). The companies operate in Pharma.

DIN 03178821
Primary Designation Director
Industry Pharma
First Appointment 06 Sep 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ananta Medicare Limited U85110DL2008PLC174677
Director06 Nov 20172008₹120 Cr (FY 2025)Active
Divyansh Exim Private Limited U74140DL2010PTC207900
Director06 Sep 20102010₹54.3 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Divyansh Exim Private Limited
Ananta Medicare Limited
Premium access

Shareholding and investment profile for Sanjay Asyja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Asyja

Sanjay Asyja was first appointed on 06 Sep 2010 as Director at Divyansh Exim Private Limited. The most recent appointment on record is 06 Nov 2017 at Ananta Medicare Limited.

Sanjay Asyja held 2 earlier board appointments: Ananta Medicare Limited (Director, 06 Nov 2017 to 12 Dec 2024); Divyansh Exim Private Limited (Director, from 06 Sep 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available